Definium Therapeutics, Inc. Proceeds from Warrant Exercises
Definium Therapeutics, Inc. (DFTX) reported Proceeds from Warrant Exercises of $6.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-06
- Definium Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2026-06-30 was $2.82M.
- Definium Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2026-03-31 was $3.83M, a 562.00% increase year-over-year.
- Definium Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-12-31 was $2.76M, a 27.99% decline year-over-year.
- Definium Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-09-30 was $425.00K.
- Definium Therapeutics, Inc. proceeds from warrant exercises for fiscal 2025 was $3.77M, a 54.44% decline from fiscal 2024.
- Definium Therapeutics, Inc. proceeds from warrant exercises for fiscal 2024 was $8.27M, a 7152.63% increase from fiscal 2023.
- Definium Therapeutics, Inc. proceeds from warrant exercises for fiscal 2023 was $114.00K, a 83.90% decline from fiscal 2022.
- Definium Therapeutics, Inc. proceeds from warrant exercises for fiscal 2022 was $708.00K, a 93.67% decline from fiscal 2021.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.65M 10-Q · filed 2026-08-06 | $9.41M derived: sum of 3 quarters · filed 2026-08-06 | $9.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.83M 10-Q · filed 2026-05-07 | $6.60M derived: sum of 2 quarters · filed 2026-05-07 | $7.02M derived: sum of 3 quarters · filed 2026-05-07 | $7.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.19M derived: sum of 2 quarters · filed 2026-02-26 | $3.19M derived: sum of 3 quarters · filed 2026-08-06 | $3.77M 10-K · filed 2026-02-26 |
| 2025-09-30 | $425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $425.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.00M 10-Q · filed 2025-11-06 | $4.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $579.00K 10-Q · filed 2026-08-06 | $4.42M derived: sum of 3 quarters · filed 2026-08-06 | $4.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $579.00K 10-Q · filed 2026-05-07 | $4.42M derived: sum of 2 quarters · filed 2026-05-07 | $4.42M derived: sum of 3 quarters · filed 2026-05-07 | $7.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.84M derived: sum of 2 quarters · filed 2026-02-26 | $6.57M derived: sum of 3 quarters · filed 2026-02-26 | $8.27M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.73M derived: sum of 2 quarters · filed 2025-11-06 | $4.43M 10-Q · filed 2025-11-06 | $4.43M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $4.43M 10-Q · filed 2025-07-31 | $4.43M derived: sum of 3 quarters · filed 2025-07-31 | |
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-08 | $1.70M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $114.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $114.00K 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $590.00K derived: sum of 3 quarters · filed 2024-02-28 | $708.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $590.00K derived: sum of 2 quarters · filed 2023-11-02 | $708.00K 10-Q · filed 2023-11-02 | $701.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $708.00K 10-Q · filed 2023-08-03 | $701.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.21M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $118.00K 10-Q · filed 2023-05-04 | $111.00K derived: sum of 2 quarters · filed 2023-05-04 | $620.00K derived: sum of 3 quarters · filed 2023-05-04 | $4.60M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $502.00K derived: sum of 2 quarters · filed 2023-03-09 | $4.48M derived: sum of 3 quarters · filed 2023-03-09 | $11.18M 10-K · filed 2023-03-09 |
| 2021-09-30 | $509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $4.49M derived: sum of 2 quarters · filed 2022-11-10 | $11.19M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $10.68M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $6.70M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $24.46M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |